J Neuberger, J Patel, H Caldwell, S Davies, V Hebditch… - Gut, 2020 - gut.bmj.com
Liver biopsy is required when clinically important information about the diagnosis, prognosis or management of a patient cannot be obtained by safer means, or for research purposes …
X Liu, D Liu, C Tan, W Feng - BMC Medical Informatics and Decision …, 2023 - Springer
Background Invasive detection methods such as liver biopsy are currently the gold standard for diagnosing liver cirrhosis and can be used to determine the degree of liver fibrosis and …
S Xin, Q Zhan, X Chen, J Xu, Y Yu - BMC gastroenterology, 2020 - Springer
Background Nonalcoholic steatohepatitis (NASH) is a key turning point during the progression of nonalcoholic fatty liver disease (NAFLD). Recent studies have shown that …
E Han, MK Kim, HW Lee, S Ryu, HS Kim, BK Jang… - …, 2022 - Wiley Online Library
Objective This study aimed to investigate the association of muscle fat contents, nonalcoholic steatohepatitis (NASH), and liver fibrosis in patients with severe obesity …
Background Bariatric surgery in patients with BMI over 50 kg/m2 is a challenging task. The aim of this study was to address main issues regarding perioperative management of these …
N Golse, C Cosse, MA Allard, A Laurenzi… - Journal of …, 2019 - Elsevier
Background & Aims Liver macrosteatosis (MS) is a major predictor of graft dysfunction after transplantation. However, frozen section techniques to quantify steatosis are often …
E Han, MK Kim, HW Lee, S Ryu, HS Kim… - The Journal of …, 2024 - academic.oup.com
Context Data on the preoperative factors for bariatric surgery response in patients with morbid obesity are limited, and there are no studies on the relationship between …
S Crommen, KP Rheinwalt, A Plamper, D Rösler… - Nutrients, 2024 - mdpi.com
Background/Objectives: Metabolic dysfunction-associated steatotic liver disease (MASLD) is closely associated with obesity and insulin resistance (IR). Identifying characteristics that …
D Meneses, A Olveira, R Corripio… - … , diabetes y nutricion, 2022 - Elsevier
Background Non-alcoholic fatty liver disease (NAFLD) is highly prevalent in morbid obesity (MO). A considerable proportion of patients with MO have non-alcoholic steatohepatitis …